GBA1 and Gaucher disease: In the literature, DNJ and FGM analogs, such as N-butyl-DNJ and N-dodecyl-DNJ, are reported to inhibit glucocerebrosidase, thereby affecting (sphingo)lipid metabolism in Gaucher disease.